Postencephalitic Parkinson Disease (Postencephalitic Parkinsonism)

27  relevant articles (1 outcomes, 2 trials/studies) found for this Disease

Postencephalitic Parkinsonism; Parkinson Disease, Postencephalitic; Parkinson Disease, Post-Encephalitic; Parkinsonian Syndrome, Postencephalitis; Parkinsonism, Postencephalitic; Post-Encephalitic Parkinson Disease; Postencephalitic Economo-Type Parkinsonism; Viral Meningoencephalitic Parkinsonism; Von Economo Encephalitis Type Parkinsonism; Economo-Type Parkinsonism, Postencephalitic; Meningoencephalitic Parkinsonism, Viral; Parkinson Disease, Post Encephalitic; Parkinsonism, Postencephalitic Economo-Type; Parkinsonisms, Viral Meningoencephalitic; Post Encephalitic Parkinson Disease; Postencephalitic Economo Type Parkinsonism; Postencephalitis Parkinsonian Syndrome; Encephalitis Lethargica Type Parkinsonism; Parkinsonism, Viral Meningoencephalitic

Relationship Network

Disease Context: Research Results

Related Diseases

1.	Parkinsonian Disorders (Parkinsonism)
2.	Parkinson Disease (Parkinson's Disease)
3.	Neurodegenerative Diseases (Neurodegenerative Disease)
4.	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
5.	Dementia (Dementias)

Experts

1.	Rudolf, J: 1 article (01/2000)
2.	Bamborschke, S: 1 article (01/2000)
3.	Schmülling, S: 1 article (01/2000)
4.	Ghaemi, M: 1 article (01/2000)
5.	Heiss, W D: 1 article (01/2000)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Postencephalitic Parkinson Disease:

1.	Dopamine (Intropin)FDA LinkGeneric 01/01/1983 - "Since Carlsson's original suggestion that dopamine may be a transmitter in the central nervous system involved in the control of motor function and that it may be involved in the Parkinsonian syndrome (Carlsson, 1959), and the now-classic paper by Ehringer and Hornykiewicz (1960) which definitively showed the significant reduction of dopamine concentration in the neostriatum of cases of idiopathic Parkinson and postencephalitic parkinsonism, the vast amount of work on the subject has focused on the biochemical and pharmacologic correlates of this dopaminergic system failure involving particularly the nigrostriatal pathways" 05/26/1961 - "The lowest mean value of urinary dopamine was found in postencephalitic Parkinsonism; the highest occurred in Wilson's disease." Order ALL the reference details at left...
2.	Melanins (Melanin)IBA 09/01/1983 - "A quantitative study of the melanin-containing dopaminergic neurons of the nigrostriatal system (A 9) and of the mesolimbic system (A 10) was carried out on Nissl-stained serial sections of nine normal brains, six age-matched brains of schizophrenics, five brains of paralysis agitans, and six brains of postencephalitic parkinsonism" Order ALL the reference details at left...
3.	Harmine (Telepathine)IBA 10/01/1991 - "The first reports of the use of banisterine to treat postencephalitic parkinsonism in 1929 created a stir in the popular press and banisterine was hailed as a "magic drug." Despite continued studies of the harmala alkaloids by other researchers, interest in the therapeutic value of these compounds vanished during the 1930's" Order ALL the reference details at left...
4.	AlkaloidsIBA 10/01/1991 - "The first reports of the use of banisterine to treat postencephalitic parkinsonism in 1929 created a stir in the popular press and banisterine was hailed as a "magic drug." Despite continued studies of the harmala alkaloids by other researchers, interest in the therapeutic value of these compounds vanished during the 1930's" Order ALL the reference details at left...
5.	antineoplaston A10 (A 10)IBA 09/01/1983 - "A quantitative study of the melanin-containing dopaminergic neurons of the nigrostriatal system (A 9) and of the mesolimbic system (A 10) was carried out on Nissl-stained serial sections of nine normal brains, six age-matched brains of schizophrenics, five brains of paralysis agitans, and six brains of postencephalitic parkinsonism" Order ALL the reference details at left...
6.	Levodopa (L Dopa)FDA LinkGeneric 08/01/1972 - "Response of patients with postencephalitic Parkinsonism to levodopa." 12/26/1970 - "Levodopa in postencephalitic parkinsonism." 11/21/1970 - "L-dopa for postencephalitic Parkinsonism." 09/26/1970 - "Side-effects of L-dopa in postencephalitic parkinsonism." 04/12/1969 - "L-dopa in postencephalitic parkinsonism." Order ALL the reference details at left...
7.	tau Proteins (tau Protein)IBA 09/01/1997 - "Immunohistochemical and biochemical analyses of hyperphosphorylated tau proteins, the major component of neurofibrillary tangles, were performed in different brain regions from patients presenting with postencephalitic parkinsonism" 09/01/1997 - "Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer's disease and other neurodegenerative disorders." 03/01/1999 - "By using biochemical and immunohistochemical methods, we confirmed that it is not found on tau proteins from biopsy- or autopsy-derived control samples, and we investigated the presence of this epitope on tau proteins in several neurodegenerative disorders, including AD, Down syndrome (DS), Guamanian amyotrophic lateral sclerosis/Parkinsonism-dementia complex (ALS/PDC), corticobasal degeneration (CBD), progressive supranuclear palsy (PSP), postencephalitic parkinsonism (PEP) and Pick's disease (PiD)" Order ALL the reference details at left...
8.	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 10/05/1988 - "The DA pattern produced by MPTP was similar to the DA loss in caudate (-98%) and putamen (-99%) observed in patients with postencephalitic parkinsonism." Order ALL the reference details at left...
9.	Trihexyphenidyl (Artane)FDA LinkGeneric 12/01/1976 - "For the treatment of 42 patients with different forms of atherosclerotic and postencephalitic parkinsonism the author used levopa drugs, medantane, cyclodol and parkopan in combination and separately" Order ALL the reference details at left...
10.	Serotonin (5 Hydroxytryptamine)IBA 01/01/1988 - "Substantial correlations of the blood serotonin levels and clinico-physiologic indices were found mostly in postencephalitic parkinsonism." Order ALL the reference details at left...

Therapies and Procedures

1.	Magic 10/01/1991 - "The first reports of the use of banisterine to treat postencephalitic parkinsonism in 1929 created a stir in the popular press and banisterine was hailed as a "magic drug." Despite continued studies of the harmala alkaloids by other researchers, interest in the therapeutic value of these compounds vanished during the 1930's" Order ALL the reference details at left...
2.	Drug Therapy (Chemotherapy) 08/01/1961 - "Drug therapy in the crises of postencephalitic parkinsonism." Order ALL the reference details at left...